Next Up:
0:00
0:00
-
Listen Listen
Health
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Sponsored message
More Stories
-
At a recent medical gathering, researchers presented their latest hypotheses about what causes – and what could treat — the lingering disease.
-
Narcan is now available over the counter, but many immigrants are unfamiliar with it.
-
The resolution, however, doesn't appear to carry much legal power behind it.
-
Studies suggest official numbers vastly underestimate heat-related injuries and illness on the job. To institute protections, the government must calculate their cost — and the cost of inaction.
-
The medication can help reverse opioid overdoses.
-
A new project invited a group of young people to tell their stories of mental health resilience on camera — and become advocates in the process.
-
The use of systems to analyze opioid-prescribing data has sparked questions over whether they have undergone enough independent testing outside of the companies that developed them, making it hard to know how they work.
-
Cases are being reported as far north as Lake County and as far south as Imperial.
-
The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits.
-
Tattoos are more popular than ever. About a third of Americans have at least one. A scientist-entrepreneur, together with a celebrity tattoo artist, believes that ink could be doing a lot more.
-
People taking weight-loss drugs Ozempic and Wegovy report a dampening of the urge to drink. Here's how the drugs curb cravings and what that could mean for helping treat addiction.
-
After a class of flame retardants called PBDEs was phased out due to links with developmental health issues, manufacturers started using another, similar group of compounds.